NCT05222724View on ClinicalTrials.gov

Efficacy of the Combination of Ibuprofen and Paracetamol in Acute Non-specific Low Back Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

October 5, 2022

Study Completion Date

October 5, 2022

Conditions
Low Back Pain
Interventions
DRUG

Tachifene

paracetamol 500 mg/ibuprofen 150 mg FDC, film-coated tablets. Two tablets 3 times daily for 3 days (i.e., every 8 hours ± 1 hour).

DRUG

Brufen

ibuprofen 600 mg, film coated tablets. One tablet 3 times daily for 3 days (i.e., every 8 hours ± 1 hour).

Trial Locations (11)

37126

Azienda Ospedaliera Universitaria Integrata di Verona, Verona

81100

"Università degli Studi della Campania Luigi Vanvitelli", Caserta

95123

Azienda Ospedaliera Universitaria Policlinico G.Rodolico, Catania

85-048

In-Vivo sp z o. o., Bydgoszcz

85-094

"Przychodnia Przy Szapitalu", Bydgoszcz

20-607

Zespół Porani Specjalistycznych Reumed Filia nr 1 Wallenroda, Lublin

60-185

Centrum Medyczne Pratia Poznan, Skorzewo

87-100

Nasz Lekarz Przychodnie Medyczne, Torun

01-864

Centrum Medyczne AstiMed, Warsaw

01-868

Centrum Medyczne PRATIA, Warsaw

02-691

Centrum Medyczne Reuma Park, Warsaw

All Listed Sponsors
collaborator

TFS Trial Form Support

INDUSTRY

lead

Aziende Chimiche Riunite Angelini Francesco S.p.A

INDUSTRY

NCT05222724 - Efficacy of the Combination of Ibuprofen and Paracetamol in Acute Non-specific Low Back Pain | Biotech Hunter | Biotech Hunter